CHATSWORTH, Calif.--(BUSINESS WIRE)--IRIS INTERNATIONAL, INC. (NASDAQ: IRIS), a leading manufacturer and developer of in vitro diagnostics systems, consumables and supplies used in automated urinalysis and body fluids testing, today announced that its senior management will be in New York City for an invitational luncheon meeting on Tues., April 10 to present to the investment community an overview of the Company’s new five-year plan, including new strategic initiatives in molecular diagnostics.
